Search

Christopher W. Fulton

Examiner (ID: 16699, Phone: (571)272-2242 , Office: P/2855 )

Most Active Art Unit
2855
Art Unit(s)
2859, 3641, 2406, 2899, 2841, 2855, 3108, 2856
Total Applications
3373
Issued Applications
2875
Pending Applications
85
Abandoned Applications
419

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5817624 [patent_doc_number] => 20060021937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Methods for removing suspended particles from soluble protein solutions' [patent_app_type] => utility [patent_app_number] => 10/698230 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5845 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20060021937.pdf [firstpage_image] =>[orig_patent_app_number] => 10698230 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/698230
Methods for removing suspended particles from soluble protein solutions Oct 30, 2003 Abandoned
Array ( [id] => 5620005 [patent_doc_number] => 20060189539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Novel GnRH analogues with antitumour effects and pharmaceutical compositions thereof' [patent_app_type] => utility [patent_app_number] => 10/695382 [patent_app_country] => US [patent_app_date] => 2003-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19899 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20060189539.pdf [firstpage_image] =>[orig_patent_app_number] => 10695382 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/695382
Novel GnRH analogues with antitumour effects and pharmaceutical compositions thereof Oct 27, 2003 Abandoned
Array ( [id] => 524076 [patent_doc_number] => 07186859 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-06 [patent_title] => 'Uses for amino acid anticonvulsants' [patent_app_type] => utility [patent_app_number] => 10/688709 [patent_app_country] => US [patent_app_date] => 2003-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14777 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/186/07186859.pdf [firstpage_image] =>[orig_patent_app_number] => 10688709 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/688709
Uses for amino acid anticonvulsants Oct 16, 2003 Issued
Array ( [id] => 7474000 [patent_doc_number] => 20040097416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'New uses for amino acid anticonvulsants' [patent_app_type] => new [patent_app_number] => 10/688638 [patent_app_country] => US [patent_app_date] => 2003-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15086 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097416.pdf [firstpage_image] =>[orig_patent_app_number] => 10688638 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/688638
Uses for amino acid anticonvulsants Oct 16, 2003 Issued
Array ( [id] => 5700611 [patent_doc_number] => 20060217296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Use of ghrelin for treating malnutrition in gastrectomized individuals' [patent_app_type] => utility [patent_app_number] => 10/530866 [patent_app_country] => US [patent_app_date] => 2003-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16896 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20060217296.pdf [firstpage_image] =>[orig_patent_app_number] => 10530866 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/530866
Use of ghrelin for treating malnutrition in gastrectomized individuals Oct 8, 2003 Issued
Array ( [id] => 5887432 [patent_doc_number] => 20060275213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Tumor targeting agents and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/530024 [patent_app_country] => US [patent_app_date] => 2003-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27488 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275213.pdf [firstpage_image] =>[orig_patent_app_number] => 10530024 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/530024
Tumor targeting agents and uses thereof Oct 2, 2003 Abandoned
Array ( [id] => 5624789 [patent_doc_number] => 20060263294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Tumor targeting agents and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/530016 [patent_app_country] => US [patent_app_date] => 2003-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 26325 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20060263294.pdf [firstpage_image] =>[orig_patent_app_number] => 10530016 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/530016
Tumor targeting agents and uses thereof Oct 2, 2003 Abandoned
Array ( [id] => 483637 [patent_doc_number] => 07220827 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-22 [patent_title] => 'Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient' [patent_app_type] => utility [patent_app_number] => 10/528771 [patent_app_country] => US [patent_app_date] => 2003-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 30 [patent_no_of_words] => 26136 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/220/07220827.pdf [firstpage_image] =>[orig_patent_app_number] => 10528771 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/528771
Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient Sep 25, 2003 Issued
Array ( [id] => 7281235 [patent_doc_number] => 20040063612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Neuroprotective agents' [patent_app_type] => new [patent_app_number] => 10/672257 [patent_app_country] => US [patent_app_date] => 2003-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11010 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063612.pdf [firstpage_image] =>[orig_patent_app_number] => 10672257 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/672257
Neuroprotective agents Sep 25, 2003 Abandoned
Array ( [id] => 7224386 [patent_doc_number] => 20040072737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Echinocandin derivatives, their method of preparation and their application as anti-fungal agents' [patent_app_type] => new [patent_app_number] => 10/666072 [patent_app_country] => US [patent_app_date] => 2003-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5698 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072737.pdf [firstpage_image] =>[orig_patent_app_number] => 10666072 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/666072
Echinocandin derivatives, their method of preparation and their application as anti-fungal agents Sep 18, 2003 Issued
Array ( [id] => 307556 [patent_doc_number] => 07531622 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-12 [patent_title] => 'Synthesis and characterization of novel systems for guidance and vectorization of molecules of therapeutic interest towards target cells' [patent_app_type] => utility [patent_app_number] => 10/528320 [patent_app_country] => US [patent_app_date] => 2003-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5241 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/531/07531622.pdf [firstpage_image] =>[orig_patent_app_number] => 10528320 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/528320
Synthesis and characterization of novel systems for guidance and vectorization of molecules of therapeutic interest towards target cells Sep 18, 2003 Issued
Array ( [id] => 5844263 [patent_doc_number] => 20060122095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Mucus formulation for mucosal surfaces and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/527690 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9053 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122095.pdf [firstpage_image] =>[orig_patent_app_number] => 10527690 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/527690
Mucus formulation for mucosal surfaces and uses thereof Sep 11, 2003 Abandoned
Array ( [id] => 7270359 [patent_doc_number] => 20040058877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Somatostatin antagonists and agonists that act at the sst subtype 2 receptor' [patent_app_type] => new [patent_app_number] => 10/658230 [patent_app_country] => US [patent_app_date] => 2003-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14758 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20040058877.pdf [firstpage_image] =>[orig_patent_app_number] => 10658230 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/658230
Somatostatin antagonists and agonists that act at the sst subtype 2 receptor Sep 7, 2003 Abandoned
Array ( [id] => 7473657 [patent_doc_number] => 20040121941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Novel inhibitors of prenylated pyrophosphate consuming enzymes' [patent_app_type] => new [patent_app_number] => 10/653069 [patent_app_country] => US [patent_app_date] => 2003-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4226 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20040121941.pdf [firstpage_image] =>[orig_patent_app_number] => 10653069 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/653069
Novel inhibitors of prenylated pyrophosphate consuming enzymes Sep 2, 2003 Abandoned
Array ( [id] => 7136004 [patent_doc_number] => 20040043934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Synthetic peptides that inhibit leukocyte superoxide anion production and/or attract leukocytes' [patent_app_type] => new [patent_app_number] => 10/651147 [patent_app_country] => US [patent_app_date] => 2003-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8808 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043934.pdf [firstpage_image] =>[orig_patent_app_number] => 10651147 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/651147
Synthetic peptides that inhibit leukocyte superoxide anion production and/or attract leukocytes Aug 27, 2003 Abandoned
Array ( [id] => 7136018 [patent_doc_number] => 20040043939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Peptide-based gemini compounds' [patent_app_type] => new [patent_app_number] => 10/647639 [patent_app_country] => US [patent_app_date] => 2003-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8740 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043939.pdf [firstpage_image] =>[orig_patent_app_number] => 10647639 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/647639
Peptide-based gemini compounds Aug 24, 2003 Abandoned
Array ( [id] => 7297212 [patent_doc_number] => 20040214765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Methods and means for inhibition of CDK4 activity' [patent_app_type] => new [patent_app_number] => 10/646267 [patent_app_country] => US [patent_app_date] => 2003-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19232 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214765.pdf [firstpage_image] =>[orig_patent_app_number] => 10646267 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/646267
Methods and means for inhibition of CDK4 activity Aug 21, 2003 Abandoned
Array ( [id] => 383111 [patent_doc_number] => 07307063 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-11 [patent_title] => 'Melanocortin metallopeptides for treatment of sexual dysfunction' [patent_app_type] => utility [patent_app_number] => 10/640755 [patent_app_country] => US [patent_app_date] => 2003-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 15006 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/307/07307063.pdf [firstpage_image] =>[orig_patent_app_number] => 10640755 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/640755
Melanocortin metallopeptides for treatment of sexual dysfunction Aug 12, 2003 Issued
Array ( [id] => 6971237 [patent_doc_number] => 20050036947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Target-specific activatable polymeric imaging agents' [patent_app_type] => utility [patent_app_number] => 10/638888 [patent_app_country] => US [patent_app_date] => 2003-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8777 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20050036947.pdf [firstpage_image] =>[orig_patent_app_number] => 10638888 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/638888
Target-specific activatable polymeric imaging agents Aug 11, 2003 Abandoned
Array ( [id] => 4575003 [patent_doc_number] => 07833532 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-16 [patent_title] => 'Immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes' [patent_app_type] => utility [patent_app_number] => 10/524936 [patent_app_country] => US [patent_app_date] => 2003-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 27000 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/833/07833532.pdf [firstpage_image] =>[orig_patent_app_number] => 10524936 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/524936
Immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes Aug 11, 2003 Issued
Menu